BRAF inhibitor response in melanoma is variable, and BRAF mutated patients often relapse. Here, the authors show that androgen receptor expression is linked to BRAF inhibitor response, and is a potential therapeutic target to increase efficacy.
- Anastasia Samarkina
- Markus Kirolos Youssef
- Gian Paolo Dotto